Skip to content
Yog Pharma
Anti-infectivesAntimalarial and disease-modifying antirheumatic drug

Hydroxychloroquine Sulfate is an antimalarial and disease-modifying antirheumatic drug indicated for malaria, lupus erythematosus and rheumatoid arthritis. We supply it to US manufacturers of tablets.

CAS747-36-4434.0 g/molC18H28ClN3O5S
2D structure of Hydroxychloroquine Sulfate, shown as the active moiety without counter-ion or water of hydration.

Data from PubChem (CID 12947) and FDA’s substance registry

CAS number

747-36-4

Molecular formula

C18H28ClN3O5S

Molecular weight

434.0g/mol

FDA UNII

IUPAC name

2-[4-[(7-chloroquinolin-4-yl)amino]pentyl-ethylamino]ethanol;sulfuric acid

InChIKey

JCBIVZZPXRZKTI-UHFFFAOYSA-N

Appearance
White or practically white crystalline powder.
Solubility
Freely soluble in water, and practically insoluble in alcohol, chloroform and ether.

Typical description, from FDA-approved labeling and pharmacopoeial monographs. The specification sent with your quote is the controlling document for any source.

Worth settling with your inquiry

A racemate supplied as the sulfate: 200 mg of the salt is equivalent to 155 mg of base.

On the US market

Reference product
PlaquenilNDA 009768
Approved ANDAs
13 with a marketed product
Approved forms and strengths
  • Tablet 100 mg, 200 mg, 300 mg, 400 mg

Single-ingredient products in FDA’s Drugs@FDA database, retrieved November 2026. The brand name belongs to its owner and identifies the reference product only.

Grade

USP or Ph. Eur. where a monograph exists, or your own specification.

Quantities

From development quantities for formulation work to commercial supply.

Packaging

To the manufacturer’s standard, typically fiber or HDPE drums with double polyethylene liners.

Regulatory filings

US DMF and CEP availability depends on the source. We confirm the filing status in writing with the quotation.

Documents available with a quote

  • Specification and certificate of analysis
  • Safety data sheet
  • Method of analysis
  • DMF letter of authorization, where a US DMF is filed
  • GMP certificate and inspection history of the site
  • Residual solvents and elemental impurities statements
  • Nitrosamine risk assessment
  • TSE/BSE statement

Need something else for your QA file? Email info@yogpharma.com